TY - JOUR
T1 - Outcome of the use of paediatric donor livers in adult recipients
T2 - A single Chinese centre experience
AU - Ju, Weiqiang
AU - Li, Cheukfai
AU - Zhang, Chuanzhao
AU - Ko, Dicken Shiu Chung
AU - Wang, Dongping
AU - Han, Ming
AU - Schroder, Paul M.
AU - Wang, Xiaoping
AU - Jiao, Xingyuan
AU - Wu, Linwei
AU - Tai, Qiang
AU - Hu, Anbin
AU - Ma, Yi
AU - Zhu, Xiaofeng
AU - Guo, Zhiyong
AU - He, Xiaoshun
N1 - Publisher Copyright:
© 2018
PY - 2019/4
Y1 - 2019/4
N2 - Background: Paediatric liver allografts sometimes are allocated to adult recipients when there are no suitable paediatric recipients on the waiting list. However, debate exits regarding the reported outcomes of liver transplants using such small grafts. Methods: Records from adult patients undergoing liver transplantation between February 2010 and January 2016 who received whole grafts from paediatric (≤ 13 years) donors or ideal deceased adult (18–35 years) donors were reviewed. Patient and graft survival, post-transplant liver function, and complications between the two groups were compared. Results: The baseline characteristics were comparable, except that the paediatric donor allografts had smaller size. The 3-month, 1-year, and 3-year rates of patient survival were 91.3%, 85.2%, and 85.2% in the paediatric donor group and 93.4%, 88.9%, and 85.0% in the adult donor group (P = 0.947), respectively. One patient receiving a paediatric allograft developed small-for-size liver syndrome post-transplantation. There was no difference in primary non-function, early allograft dysfunction, biliary complications, vascular complications, or infection between the two groups. Conclusion: Our study indicates that using paediatric donor livers in well-selected adult recipients is a safe procedure, considering there was no suitable paediatric recipient. However, the risk of portal hyperperfusion should be considered in clinical cases such as size-mismatched transplants.
AB - Background: Paediatric liver allografts sometimes are allocated to adult recipients when there are no suitable paediatric recipients on the waiting list. However, debate exits regarding the reported outcomes of liver transplants using such small grafts. Methods: Records from adult patients undergoing liver transplantation between February 2010 and January 2016 who received whole grafts from paediatric (≤ 13 years) donors or ideal deceased adult (18–35 years) donors were reviewed. Patient and graft survival, post-transplant liver function, and complications between the two groups were compared. Results: The baseline characteristics were comparable, except that the paediatric donor allografts had smaller size. The 3-month, 1-year, and 3-year rates of patient survival were 91.3%, 85.2%, and 85.2% in the paediatric donor group and 93.4%, 88.9%, and 85.0% in the adult donor group (P = 0.947), respectively. One patient receiving a paediatric allograft developed small-for-size liver syndrome post-transplantation. There was no difference in primary non-function, early allograft dysfunction, biliary complications, vascular complications, or infection between the two groups. Conclusion: Our study indicates that using paediatric donor livers in well-selected adult recipients is a safe procedure, considering there was no suitable paediatric recipient. However, the risk of portal hyperperfusion should be considered in clinical cases such as size-mismatched transplants.
KW - Adult recipients
KW - Clinical outcome
KW - Liver transplantation
KW - Paediatric donor
UR - http://www.scopus.com/inward/record.url?scp=85054581112&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054581112&partnerID=8YFLogxK
U2 - 10.1016/j.clinre.2018.08.018
DO - 10.1016/j.clinre.2018.08.018
M3 - Article
C2 - 30318357
AN - SCOPUS:85054581112
SN - 2210-7401
VL - 43
SP - 148
EP - 154
JO - Clinics and Research in Hepatology and Gastroenterology
JF - Clinics and Research in Hepatology and Gastroenterology
IS - 2
ER -